Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2023 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2023 First Quarter Financial Results

ST. LOUIS, May 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
April 18, 2023 09:05 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023

ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
April 13, 2023 09:06 ET | Source: Stereotaxis, Inc.

Over 1,000 Cardiac Patients Treated with Genesis Robotic System

ST. LOUIS, April 13, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that over...
March 20, 2023 08:08 ET | Source: Stereotaxis, Inc.

Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders

ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand...
March 03, 2023 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2022 Full Year Financial Results

ST. LOUIS, March 03, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
February 21, 2023 09:03 ET | Source: Stereotaxis, Inc.

Stereotaxis to Present at Cowen 43rd Annual Health Care Conference

ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
February 02, 2023 09:05 ET | Source: Stereotaxis, Inc.

Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

ST. LOUIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
December 20, 2022 09:04 ET | Source: Stereotaxis, Inc.

Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System

ST. LOUIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of...
November 28, 2022 09:07 ET | Source: Stereotaxis, Inc.

Stereotaxis to Participate in Piper Sandler 34th Annual Healthcare Conference

ST. LOUIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
November 10, 2022 09:00 ET | Source: Stereotaxis, Inc.

Stereotaxis Reports 2022 Third Quarter Financial Results

ST. LOUIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right